SCHEMBL26435709

SCHEMBL26435709

c1ccc(-n2c3ccccc3c3ccc(-c4nc(-c5ccc(-c6cccc7ccc8ccccc8c67)cc5)nc(-c5cccc6c5oc5ccccc56)n4)cc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.36
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
KDM4E B2RXH2 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
PRKDC P78527 3/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
MAPT P10636 2/20 0.31
TDP1 Q9NUW8 1/20 0.31
TSHR P16473 3/20 0.30
LMNA P02545 2/20 0.30
HSD17B10 Q99714 2/20 0.30
MAPK1 P28482 1/20 0.30
ALDH1A1 P00352 2/20 0.30
POLB P06746 2/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
MEN1 O00255 1/20 0.30
BRCA1 P38398 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26434991 0.97 ALOX5 (0.37) ALOX5SIRT2SIRT1KDM4EL3MBTL1
SCHEMBL26435050 0.95 ALOX5 (0.36) ALOX5SIRT2SIRT1KDM4EL3MBTL1
SCHEMBL26435710 0.94 ALOX5 (0.36) ALOX5SIRT2SIRT1KDM4EL3MBTL1
SCHEMBL26435552 0.94 ALOX5 (0.36) ALOX5SIRT2SIRT1KDM4EPRKDC
SCHEMBL26435056 0.93 ALOX5 (0.35) ALOX5SIRT2SIRT1KDM4EL3MBTL1
SCHEMBL23134224 0.93 ALOX5 (0.38) ALOX5SIRT2SIRT1KDM4EL3MBTL1
SCHEMBL26435714 0.93 ALOX5 (0.38) ALOX5SIRT2SIRT1KDM4EL3MBTL1
SCHEMBL26435002 0.92 ALOX5 (0.37) ALOX5SIRT2SIRT1KDM4EL3MBTL1
SCHEMBL16810881 0.91 ALOX5 (0.41) ALOX5KDM4EL3MBTL1ATMPRKDC
SCHEMBL26052263 0.91 ALOX5 (0.43) ALOX5SIRT2SIRT1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885SIRT2 3665/4885SIRT1 3574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.